Enterprise Value
341.5M
Cash
131.7M
Avg Qtr Burn
-17.74M
Short % of Float
8.79%
Insider Ownership
48.14%
Institutional Own.
11.87%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Human Acellular Vessel (HAV) Details End-Stage Renal Disease | Phase 3 Data readout | |
Human Acellular Vessel Details Vascular Trauma | Phase 2/3 Data readout |